Molecular markers have greater impact on risk of recurrence than cancer stage and PSA levels

Dr. Robert Bristow, MD of Princess Margaret Cancer Centre discusses molecular markers have greater impact on risk of recurrence than cancer stage and PSA levels at ASCO GU 2016